CCL19 and congenital rubella syndrome: The rarer ‘cytokine release syndrome’ (CRS) signature found in 26% of patients showed minimal deviation in gene expression from the control group, but was marked by the proliferation of NK-T-cells, and enhanced production of cytokines such as IL1 and CCL19.